Buy Tesla ahead of potential SpaceX merger, says Barclays

Barclays upgraded Tesla to overweight from equal weight and raised its price target to $450 from $370, implying 21% upside from Friday’s close, citing the possibility of a Tesla-SpaceX combination and growth in Tesla’s businesses. Musk called a merger a “good idea,” and committees at both companies have been formed to discuss a potential combination; no deal has been announced. Barclays also cited a potential auto recovery, energy shipments growing more than 50%, and rising robotaxi miles, while Tesla shares remain down more than 17% year to date.

Analysis

The upgrade’s key risk is that it capitalizes a merger premium before there is a defined transaction. A combination could transfer value between Tesla and SpaceX through exchange terms, dilution, governance, and allocation of capital—not simply add SpaceX’s value to Tesla’s. Until structure and terms are public, there is no defensible deal-arbitrage spread; any merger-driven move is vulnerable to a sharp reversal if discussions stall or the proposed terms disappoint.

The more durable bull case rests on converting operating claims into cash generation. Energy demand from data centers could support a higher-growth mix, but backlog is not revenue: delivery capacity, project timing, and realized economics need verification. Likewise, rising robotaxi miles matter only if they translate into paid rides, acceptable safety outcomes, and scalable unit economics; Waymo remains a competitive constraint. Over 1–3 months, watch transaction disclosures and delivery/backlog conversion. Over 6–18 months, the test is whether auto recovery and energy growth offset competitive and execution pressure in autos.

Contrarian view: the analyst upgrade may have limited incremental information when the stock already has substantial buy/hold coverage, while the headline catalyst is unusually speculative. The risk/reward is therefore better framed as conditional operating optionality than as a merger bet. Falsifiers include talks ending, weaker auto guidance or deliveries, energy backlog failing to convert, or robotaxi activity rising without evidence of commercial scale.

Key Decisions for Investors

• Do not treat the reported committee discussions as a completed or near-certain transaction. Keep any merger premium out of base-case valuation until there are disclosed terms, financing/exchange mechanics, and a credible path through governance and regulatory review.
• For a bullish exposure, prefer a staged TSLA position rather than chasing a merger headline: add only as operating evidence supports the thesis. Reassess on delivery/guidance updates and verified energy shipments; cut the thesis if auto performance weakens or claimed backlog does not convert into reported revenue.
• Avoid a TSLA–SPCX merger-arbitrage trade for now: without transaction terms and a defined consideration mix, there is no measurable spread or reliable hedge ratio. Monitor for formal filings or a disclosed proposal before sizing event risk.
• Treat robotaxi miles as a watch item, not yet a standalone valuation catalyst. Look for paid-trip growth, service-area expansion, and safety/regulatory milestones; increasing miles without commercial proof would weaken the bull case relative to Waymo.